| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |